Correlates of abnormal urinary albumin excretion rates among primary care patients with essential hypertension

Journal of the American Board of Family Practice

Volumn 10, Issue 3, 1997, Pages 180-184

  Spangler, John G ^a   Bell, Ronny A ^a   Summerson, John H ^a   Konen, Joseph C ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ALBUMINURIA; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; SMOKING; STATISTICAL MODEL; URINE;

ALBUMINURIA; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; SMOKING;

EID: 0031132896     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-60.
2. Haffner SM, Morales PA, Gruber MK, Hazuda HP, Stern MP. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arterioscler Thromb 1993;13:205-10.
3. Allawi J, Jarrett RJ. Microalbuminuria and cardiovascular risk factors in type 2 diabetes mellitus. Diabet Med 1990;7:115-8.
4. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for cardiovascular risk factors in non-diabetic subjects? Arteriosclerosis 1990;10:727-31.
5. Bulpitt CJ, Beevers DG, Butler A, Coles EC, Hunt D, Munro-Faure AD, et al. The survival of treated hypertensive patients and their cause of death: a report from the DHHS hypertensive care computing project (DHCCP). J Hypertens 1986;4:93-9.
6. Redon J, Liao Y, Lozano JV, Miralles A, Baldo E, Cooper RS. Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens 1994;7:801-7.
7. Scarpelli PT, Chegai E, Castigli E, Livi R, Cagnoni M, Cappelli G. Renal handling of albumin and beta-2-microalbumin in human hypertension. Nephron 1985;40:122-3.
8. Lewin A, Blaufox MD, Castle H, Entwisle G, Langford H. Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med 1985;145:424-7.
9. Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, et al. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Goteborg, Sweden. J Hypertens 1985;3:167-76.
10. Woff FW, Lindeman RD. Effects of treatment in hypertension. Results of a controlled study. J Chronic Dis 1966;19:227-40.
11. Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984;108:1347-52.
12. Ljungman S, Aurell M, Hartford M, Wikstrand J, Wilhelmsen L, Berglund G. Blood pressure and renal function. Acta Med Scand 1980;208:17-25.
13. Rostand SG, Brown G, Krik KA, Rutsky EA, Dustan HP. Renal insufficiency in treated essential hypertension. N Engl J Med 1989;320:684-8.
14. Ruilope LM, Alcazar JM, Hernandez E, Moreno F, Martinez MA, Rodicio JL. Does an adequate control of blood pressure protect the kidney in essential hypertension? J Hypertens 1990;8:525-31.
15. Konen JC, Curtis LC, Shihabi ZK, Dignan MB. Screening diabetic patients for microalbuminuria. J Fam Pract 1990;31:505-10.
16. McCormick CP, Shihabi ZK, Konen JC. Microtransferrinuria and microalbuminuria: enhanced immunoassay. Ann Clin Lab Sci 1989;19:444-51.
17. EpiInfo [computer program]. Version 6.0. Atlanta: Centers for Disease Control and Prevention, 1994.
18. SPSS-PC+ advanced statistics, 4.0 [computer program]. Chicago: SPSS, 1990.
19. Mimran A, Ribstein J. Microalbuminuria in essential hypertension. Clin Exp Hypertens 1993;15:1061-7.
20. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-26.
21. Cerasola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Carapelle E, et al. Microalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens Suppl 1989;7:S332-3.
22. Bönner G. Hyperinsulinemia, insulin resistance, and hypertension. J Cardiovasc Pharmacol 1994;24 (Suppl 2):S39-49.
23. McCarty ME Insulin resistance - not hyperinsulin-emia - is pathogenic in essential hypertension. Med Hypothesis 1994;42:226-36.
24. Bianchi S, Bigazzi R, Quinones-Galvan A, Muscelli E, Baldari G, Pecori N, et al. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension 1995;26:789-95.
25. Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990;33:470-6.
26. Norgaard K, Jensen T, Feldt-Rasmussen B. Effects of isradipine in type 1 (insulin-dependent) diabetic patients with albuminuria and normal blood pressure. J Hum Hypertens 1992;6:145-50.
27. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-25.
28. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 1986;4:515-24.
29. Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975;36:319-27.
30. King GL, Goodman AD, Buzney S, Moses A, Kahn CR. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985;75:1028-36.
31. Konen JC, Shihabi ZK. Microalbuminuria and diabetes mellitus. Am Fam Physician 1993;48:1421-8.
32. Tung P, Ginier P, Levin SR, Hershman JD, Hershman JM. Clinical characteristics associated with microalbuminuria in an adult diabetic population. J Diabet Complications 1990;4(1):15-20.